pcDNA3-H-Ras_V12 Citations (3)

Originally described in: Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras.
Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J Cell. 1997 May 2;89(3):457-67. PubMed Journal

---

Articles Citing pcDNA3-H-Ras_V12

Articles
Oxidative Dimerization of PHD2 is Responsible for its Inactivation and Contributes to Metabolic Reprogramming via HIF-1alpha Activation. Lee G, Won HS, Lee YM, Choi JW, Oh TI, Jang JH, Choi DK, Lim BO, Kim YJ, Park JW, Puigserver P, Lim JH. Sci Rep. 2016 Jan 7;6:18928. doi: 10.1038/srep18928. PubMed
ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition. Ruicci KM, Pinto N, Khan MI, Yoo J, Fung K, MacNeil D, Mymryk JS, Barrett JW, Nichols AC. Oral Oncol. 2018 Sep;84:95-103. doi: 10.1016/j.oraloncology.2018.07.010. Epub 2018 Jul 27. PubMed
A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer. Liu W, Gajendran B, Sample KM, Wang C, Hu A, Chen B, Li Y, Zacksenhaus E, Ben-David Y. Cancer Gene Ther. 2022 Apr 27. pii: 10.1038/s41417-022-00471-4. doi: 10.1038/s41417-022-00471-4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.